Human papillomavirus infections among couples in new sexual relationships

Epidemiology

Volumn 21, Issue 1, 2010, Pages 31-37

  Burchell, Ann N ^a   Tellier, Pierre Paul ^a   Hanley, James ^a   Coutlée, François ^a,b   Franco, Eduardo L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; COLLEGE; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PENIS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; QUESTIONNAIRE; SCROTUM; SELF REPORT; SEXUAL BEHAVIOR; SEXUALITY; UNIVERSITY; VAGINA; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

ADOLESCENT; ALPHAPAPILLOMAVIRUS; COHORT STUDIES; FEMALE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; QUEBEC; QUESTIONNAIRES; SEXUAL BEHAVIOR; SEXUAL PARTNERS; URBAN POPULATION; VAGINAL SMEARS; YOUNG ADULT;

EID: 73849104351     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181c1e70b     Document Type: Article

References (36)

1. Aral SO, Holmes KK. The epidemiology of STIs and their social and behavioral determinants: Industrialized and developing countries. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Diseases. 4th ed. New York: McGraw Hill Medical; 2008:53-92.
2. Trottier H, Franco E. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24:S4-S15.
3. Dunne E, Nielson C, Stone K, Markowitz L, Giuliano A. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis. 2006;194:1044-1057.
4. International Agency for Research on Cancer (IARC) Working Group. Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol.64. Lyon, France: International Agency for Research on Cancer; 1995.
5. Parkin D. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030-3044.
6. Bleeker MCG, Snijders PFJ, Voorhorst FJ, Meijer CJLM. Flat penile lesions: The infectious "invisible" link in the transmission of human papillomavirus. Int J Cancer. 2006;119:2505-2512.
7. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Epidemiology and transmission dynamics of genital human papillomavirus infection. Vaccine. 2006;24:S52-S61.
8. Baken L, Koutsky L, Kuypers J, et al. Genital human papillomavirus infection among male and female sex partners: prevalence and typespecific concordance. J Infect Dis. 1995;171:429-432.
9. Kyo S, Inoue M, Koyama M, Fujita M, Tanizawa O, Hakura A. Detection of high-risk human papillomavirus in the cervix and semen of sex partners. J Infect Dis. 1994;170:682-685.
10. Hippeläinen M, Yliskoski M, Syrjänen S, et al. Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis. 1994;21:76-82.
11. Bleeker M, Hogewoning C, Berkhof J, et al. Concordance of specific human papillomavirus types in sex partners is more prevalent that would be expected by chance and is associated with increased viral loads. Clin Infect Dis. 2005;41:612-620.
12. Castellsagué X, Ghaffari A, Daniel R, Bosch F, Munoz N, Shah K. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Columbia. J Infect Dis. 1997;176:353-361.
13. Franceschi S, Castellsagué X, Dal Maso L, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer. 2002;86:705-711.
14. Thomas D, Ray R, Kuypers J, et al. Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers. Am J Epidemiol. 2001;153:740-748.
15. Castellsagué X, Bosch F, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002;346:1105-1112. (Pubitemid 34984600)
16. Lu B, Wu Y, Nielson CM, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: A prospective study. J Infect Dis. 2009;199:362-371.
17. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218-226.
18. Moscicki A, Hills N, Shiboski S, et al. Risks for incidence human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001;285:2995-3002.
19. Giuliano A, Harris R, Sedjo R, et al. Incidence, prevalence and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis. 2002;186:462-469.
20. Partridge J, Hughes J, Feng Q, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis. 2007;196:1128-1136.
21. Oriel JD. Natural history of genital warts. Br J Vener Dis. 1971;47:1-13.
22. Burchell A, Richardson H, Mahmud S, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol. 2006;163:534-543.
23. Burchell A, Tellier P, Hanley J, Coutlée F, Franco E. Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner. Sex Transm Dis. 2009 Aug 21.-Epub 2009 Aug 21.
24. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis. 2004;189:677-685.
25. Coutlée F, Rouleau D, Petignat P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J Clin Microbiol. 2006;44:1998-2006.
26. Ho L, Tay SK, Chan SY, Bernard HU. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis. 1993;168:803-809.
27. Strand A, Rylander E, Wilander E, Zehbe I. HPV infection in male partners of women with squamous intraepithelial neoplasia and/or highrisk HPV. Acta Derm Venereol. 1995;75:312-316.
28. Hernandez B, Wilkens L, Zhu X, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis. 2008;14:888-894.
29. Giuliano A, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26:K17-K28.
30. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004;96:604-615.
31. Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis. 2004;10:1915-1923.
32. Garnett G, Kim J, French K, Goldie S. Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine. 2006; 24:S178-S186.
33. Kulasingam S, Connelly L, Conway E, et al. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. Sex Health. 2007;4:165-175.
34. Brisson M, Van de Velde N, De Wals P, Boily MC. The potential cost effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine. 2007;25:5399-5408.
35. Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007;13:28-41.
36. Sanders G, Taira AV. Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg Infect Dis. 2003;9:37-48.